相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chemoprevention of Oesophageal Squamous-Cell Carcinoma and Adenocarcinoma: A Multicentre Retrospective Cohort Study
Junya Arai et al.
DIGESTION (2022)
Proton pump inhibitors may reduce the risk of high-grade dysplasia and/or esophageal adenocarcinoma in Barrett's esophagus: a systematic review and meta-analysis
Haijuan Yao et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2022)
The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H2 Receptor Antagonists with Clinical Complications in Patients with Severe Sepsis
Jiamin Gao et al.
DISEASE MARKERS (2022)
Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER-Medicare Analysis
Holli A. Loomans-Kropp et al.
CANCER PREVENTION RESEARCH (2021)
Prevalence of Proton Pump Inhibitor Use Among Patients With Cancer
Jean-Luc Raoul et al.
JAMA NETWORK OPEN (2021)
Trends in conditional overall survival of esophageal cancer: a population-based study
Wei Deng et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
The association between acid-suppressive agent use and the risk of cancer: a systematic review and meta-analysis
Hyun Jin Song et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade
Jianjun Yang et al.
FRONTIERS IN ONCOLOGY (2020)
Esophageal Cancer: An Updated Surveillance Epidemiology and End Results Database Analysis
Eric Omar Then et al.
WORLD JOURNAL OF ONCOLOGY (2020)
Publication bias examined in meta-analyses from psychology and medicine: A meta-meta-analysis
Robbie C. M. van Aert et al.
PLOS ONE (2019)
Prevalence and risk factors for Barrett's esophagus in Taiwan
Yan-Hua Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer
Nele Brusselaers et al.
CANCER EPIDEMIOLOGY (2019)
Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans
M. C. Tan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Esophageal cancer: Risk factors, genetic association, and treatment
Fang-Liang Huang et al.
ASIAN JOURNAL OF SURGERY (2018)
Maintenance proton pump inhibition therapy and risk of oesophageal cancer
Nele Brusselaers et al.
CANCER EPIDEMIOLOGY (2018)
Factors Associated With Progression of Barrett's Esophagus: A Systematic Review and Meta-analysis
Rajesh Krishnamoorthi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
Janusz A. Z. Jankowski et al.
LANCET (2018)
Lack of incremental effect of histamine receptor antagonists over proton pump inhibitors on the risk of neoplastic progression in patients with Barrett's esophagus: a cohort study
Prashanthi N. Thota et al.
JOURNAL OF DIGESTIVE DISEASES (2017)
Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis
Qiang Hu et al.
PLOS ONE (2017)
Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort
Rajesh Krishnamoorthi et al.
GASTROINTESTINAL ENDOSCOPY (2016)
Etiology and Prevention of Esophageal Cancer
Chung S. Yang et al.
GASTROINTESTINAL TUMORS (2016)
NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study
Gwen M. C. Masclee et al.
BMJ OPEN (2015)
Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients
F. Hvid-Jensen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
710 Proton Pump Inhibitor Use but Not Statin Use Is Associated With Decreased Risk for High-grade Dysplasia and Esophageal Adenocarcinoma in Patients With Barrett's Esophagus: Results From a Large, Multicenter Cohort Study
Srinivas Gaddam et al.
GASTROENTEROLOGY (2014)
Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis
Siddharth Singh et al.
GUT (2014)
Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus
Florine Kastelein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study
Kalliopi Alexandropoulou et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Epidemiology and Natural History of Intestinal Metaplasia of the Gastroesophageal Junction and Barrett's Esophagus: A Population-Based Study
Kee Wook Jung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Can Progression to Dysplasia in Barrett's Esophagus Be Prevented by Proton Pump Inhibitors?
Johnny Altawil et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus
Dang M. Nguyen et al.
GASTROENTEROLOGY (2010)
Antacid Drug Use and Risk of Esophageal and Gastric Adenocarcinomas in Los Angeles County
Lei Duan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Medication Usage and the Risk of Neoplasia in Patients With Barrett's Esophagus
Dang M. Nguyen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus
L. C. Hillman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Subsite-specific risk factors for esophageal and gastric adenocarcinoma
Sarah J. Crane et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
L. A. Garcia Rodriguez et al.
GUT (2006)
Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus
Pieter J. F. de Jonge et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence
BT Cooper et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
LC Hillman et al.
MEDICAL JOURNAL OF AUSTRALIA (2004)
Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses
LL Kjaergard et al.
ANNALS OF INTERNAL MEDICINE (2001)
H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study
UL Suleiman et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2000)
An age, period and cohort analysis of pleural cancer mortality in Europe
C La Vecchia et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2000)
分享论文
